Vical Provides Vaxfectin(R) Review at Novel Vaccines: Adjuvants & Delivery Systems Conference
- 6:30 AM — Aug 17 —
- Source: PrimeZone Media Network
BOSTON, Aug. 17, 2011 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that the company will present a summary of data highlighting the broad potential applications for the company's Vaxfectin ® adjuvant at the Third Annual Novel Vaccines: Adjuvants & Delivery Systems Conference, (Boston – August 16-18). Read More
Advertisement
John Doukas
Exclusives
John Doukas
On Sale
Hot Music News
New Lana Del Rey Controversy
Does Lana Have Another Secret Alter Ego?
Celebrity Diets
Jessica Simpson Talks Weight Struggles
Rihanna's Eyebrow-Raising Cover Shoot
See RiRi Pose Topless on the Newest 'Esquire'
Smokin' Hot Celebs Over 40
You Won't Believe How Old These Sexy Stars Are